Ryman’s turnaround is well under way: Forsyth Barr

Ryman’s turnaround is well under way: Forsyth Barr
Forsyth Barr's Aaron Ibbotson rates Ryman shares as "outperform". (Image: Forsyth Barr)
Jenny Ruth
Forsyth Barr analyst Aaron Ibbotson has taken a deep dive into Ryman Healthcare‘s debt position and its turnaround strategy and concluded it is “changing its stripes more than the market is giving it credit for”.The market has certainly exhibited extreme disillusion with the stock in recent weeks.Ryman shares fell as low as $4.82 after it completed its $902 million capital raising, compared with the rights issue price of $5 per new share and $6.40 before the mid-February announcement.The shares closed at $5.22 on Tuesday.A goo...

More Markets

Robust update from Tauranga Port perks up NZX
Markets Market close

Robust update from Tauranga Port perks up NZX

Numbers hide 'a lot of paddling' going on under the surface. 

Graham Skellern 25 Oct 2024
Jarden upgrades Michael Hill ahead of Christmas
Finance

Jarden upgrades Michael Hill ahead of Christmas

Since a Wednesday trading update, company's shares have risen 9%.

Gregor Thompson 25 Oct 2024
NZ Windfarms buys NZ's oldest windfarm
Infrastructure

NZ Windfarms buys NZ's oldest windfarm

Bottom end of ebitdaf guidance is $1.5m higher than previous estimate.

John Anthony 25 Oct 2024
Winton chair defends Sunfield development
Property

Winton chair defends Sunfield development

Winton wants to develop the Sunfield masterplanned community at Takanini.

Gregor Thompson 25 Oct 2024